Clinical Trial

Endogenous Energy Production in Critically Ill Patients

Study acronym: eEPIC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to investigate when critically ill patients transition from a non-suppressible catabolism to a normal response to feeding. Endogenous production of glucose, fat and protein will be studied on a minimum of two occasions in mechanically ventilated ICU patients, in a fasted state and during parenteral nutrition. Substrate kinetics are estimated by a tracer dilution method using infusions of isotopically labeled glucose, glycerol and phenylalanine. Blood sampling for metabolomics analysis will be performed to elucidate potential biomarkers indicating an anabolic response to nutrition.
Trial Details
NCT Number NCT07059988
Lead Sponsor Karolinska University Hospital
Conditions Critical Illness, Metabolism and Nutrition Disorder
Enrollment 40 participants
Start Date 2025-07
Primary Completion 2026-12 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2025-07-11